FDA DISPROVES CONSUMERS' FOUNDATION COOKING OIL TEST 20161001 公視晨間新聞

(1:51)

CDC disproves Ibuprofen rumor

(1:5)

Decongestant ingredient deemed ineffective: FDA

(2:27)

FDA D.I.S.C.O. Burst Edition: FDA approvals of Trodelvy (sacituzumab govitecan) for locally advan...

(5:31)

HEALTHY COLORADO: FDA proposes to remove ingredient used in common decongestants due to ...

(3:21)

U.S. FDA panel says popular decongestant doesn't work

(1:50)

Popular decongestants don't actually work, FDA panel says

(10:39)

FDA panel determines popular decongestant doesn't work

(3:1econd)

Research, faith, science, future threat

(1:10:48)

FDA: Popular OTC medicines for colds and allergies don’t work

(4:20)

Vitamin D and Immunity, Lots of Evidence

(30:26)

Could ineffective nasal decongestants be pulled from shelves?

(7:14)

June 10, 2024 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee (PCNS)

(7:26:41)

Popular nasal decongestants like Sudafed, NyQuill are ineffective, FDA says | LiveNOW from FOX

(9:14)

Nonprescription Drug Product with an Additional Condition for Nonprescription Use

(55:40)

FDA pulls some cold medications from shelves for being 'useless' | NewsNation Now

(4:17)

FDA says some cold and allergy drugs have an ineffective key ingredient

(3:48)

FDA reevaluating whether over-the-counter decongestant really works

(2:24)

FDA D.I.S.C.O. Burst Edition: FDA approval of Cabometyx (cabozantinib) for locally advanced or me...

(3:1econd)

FDA D.I.S.C.O. Burst Edition: FDA approval of Keytruda (pembrolizumab) for the adjuvant treatment...

(3:31)

FDA D.I.S.C.O. Burst Edition: FDA approval of Rezurok (belumosudil) for adult and pediatric patie...

(3:31)

FDA D.I.S.C.O. Burst Edition: FDA approval of Zynyz (retifanlimab-dlwr) for metastatic or recurre...

(2:31)

FDA D.I.S.C.O. Burst Edition: FDA approval of Tafinlar (dabrafenib) with Mekinist (trametinib) fo...

(4:1econd)

FDA Says Common Decongestant is Not Effective | September 20, 2023 | News 19 at 5 p.m.

(2:40)

FDA D.I.S.C.O. Burst Edition: FDA approval of Keytruda (pembrolizumab) for patients with metastat...

(3:31)

Plastic Usage: FDA refutes alleged health risk in taking alcohol from polythene containers (13-9-22)

(2:34)

FDA D.I.S.C.O. Burst Edition: FDA approval of Tibsovo (ivosidenib) for patients with relapsed or ...

(3:31)

FDA D.I.S.C.O. Burst Edition: FDA approval of Brukinsa (zanubrutinib) for adult patients with Wal...

(3:1econd)

FDA D.I.S.C.O. Burst Edition: FDA approval of Lenvima (lenvatinib) in combination with Keytruda (...

(3:30)